KNJC’s Nosno spray sales brisk in pharmacy market

Published: 2012-03-30 06:56:00

Updated: 2012-03-30 06:56:00

KNJC Korea saw its pharmacy sales of Nosno spray, anti-snoring nasal spray, jump this year on the back of the successive approvals from the U.S. Food and Drug Administration and the Korea Food and Food and Administration.

The company’s first-quarter sales of the Nosno increased by 37.8 percent...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK